DAmour Kevin 4
4 · Brooklyn ImmunoTherapeutics, Inc. · Filed Jun 29, 2022
Insider Transaction Report
Form 4
DAmour Kevin
See Remarks
Transactions
- Tax Payment
Common Stock
2022-06-28$0.55/sh−6,077$3,363→ 11,496 total - Exercise/Conversion
Restricted Stock Units
2022-06-28−17,573→ 52,717 total→ Common Stock (17,573 underlying) - Exercise/Conversion
Common Stock
2022-06-28+17,573→ 17,573 total
Footnotes (2)
- [F1]Each restricted stock unit converts into one share of common stock.
- [F2]On June 28, 2021, the reporting person was granted 70,290 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.